All‐cause mortality · otherwise healthy children aged 6 months to 12 years of age
Zinc supplementation showed no clear difference in all‐cause mortality compared with no zinc supplementation (high certainty).
1 finding from 1 review
All‐cause mortality · children aged between 6 months and 5 years
Vitamin A supplementation leads to lower all‐cause mortality compared with placebo or usual care (high certainty).
1 finding from 1 review
All‐cause mortality · adults aged 18‐59 years with primary hypertension (mild to moderate systolic or diastolic hypertension)
Antihypertensive drug therapy showed no clear difference in all‐cause mortality compared with control (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · children (aged 6 to 11 years) being overweight or obese
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality · adolescents (aged 12‐17 years) being overweight or obese
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · children under 5 years of age
1 finding from 1 review
Intervention not reported
All‐cause mortality · preschool children (aged 0 to 6 years) with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality · preschool children (aged 0 to 6 years) with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · children under 12 years of age
1 finding from 1 review
Mortality due to all‐cause diarrhea · otherwise healthy children aged 6 months to 12 years of age
Zinc supplementation showed no clear difference in mortality due to all‐cause diarrhea compared with no zinc supplementation (moderate certainty).
1 finding from 1 review
All‐cause mortality · children aged 6 to 23 months
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · children aged 6 to 23 months
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality at 5 years · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
All‐cause mortality · adults (18 years of age or older) with hypertension‐induced left ventricular hypertrophy
It is very uncertain whether antihypertensive therapy changes all‐cause mortality compared with placebo or no treatment (very low certainty).
1 finding from 1 review
All‐cause mortality · general population over 2 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · general population over 2 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · general population over 2 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · General population, as well as age‐specific subgroups (< 1 year; < 14 years; > 65 years)
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
All‐cause mortality · adults aged 18 years or over undergoing general anaesthesia for non‐cardiac or non‐neurosurgical elective operations
The intervention showed no clear difference in all‐cause mortality (low certainty).
1 finding from 1 review
All‐cause mortality · people > 18 years of age with a diagnosed deep vein thrombosis
Idrabiotaparinux showed no clear difference in all‐cause mortality compared with idraparinux (low certainty).
1 finding from 1 review